Search Result "c-Met enzyme"
HGF/c-MET: A Potential Target for the Treatment of Various Cancers
Journal: Current Enzyme Inhibition
Volume: 19 Issue: 2 Year: 2023 Page: 71-80
Author(s): Dinesh Kumar Chellappan,Sachin Kumar Singh,Sabapathi Mohana Lakshmi
Targeting c-MET/HGF Signaling Pathway in Upper Gastrointestinal Cancers: Rationale and Progress
Journal: Current Drug Targets
Volume: 15 Issue: 14 Year: 2014 Page: 1302-1311
Author(s): Sharareh Gholamin,Hamid Fiuji,Mina Maftouh,Reza Mirhafez,Fatemeh Homaei Shandiz,Amir Avan
Efficacy of Therapy with c-Met/HGF Inhibitors in Solid Tumors: A Systematic Review Based on 24 Clinical Trials
Journal: Clinical Cancer Drugs
Volume: 3 Issue: 2 Year: 2016 Page: 87-99
Author(s): Yin Yin,He Wang,Mingjie Lu,Wei Zhu
Recent Advances in the Design and Synthesis of c-Met Inhibitors as Anticancer Agents (2014-Present)
Journal: Current Medicinal Chemistry
Volume: 24 Issue: 1 Year: 2017 Page: 57-64
Author(s): Peng-Cheng Lv,Zhong-Chang Wang,Hai-Liang Zhu
An Orally Bioavailable c-Met Kinase Inhibitor Potently Inhibits Brain Tumor Malignancy and Growth
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10 Issue: 1 Year: 2010 Page: 28-35
Author(s): Fadila Guessous, Ying Zhang, Charles diPierro, Lukasz Marcinkiewicz, Jann Sarkaria, David Schiff, Sean Buchanan, Roger Abounader
Clustering and Sampling of the c-Met Conformational Space: A Computational Drug Discovery Study
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 22 Issue: 9 Year: 2019 Page: 635-648
Author(s): Korosh Mashayekh,Shahrzad Sharifi,Tahereh Damghani,Maryam Elyasi,Mohammad S. Avestan,Somayeh Pirhadi
Novel [1,2,4] Triazol [4,3-a] Pyridine Derivatives as Potential Selective c-Met Inhibitors with Improved Pharmacokinetic Properties
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17 Issue: 8 Year: 2017 Page: 1102-1112
Author(s): Junjun Zhao,Shaohua Gou,Xiaobing Zhang,Yan Liang,Lei Fang
Enhancement of the Antiproliferative Activity of Gemcitabine by Modulation of c-Met Pathway in Pancreatic Cancer
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 5 Year: 2013 Page: 940-950
Author(s): Amir Avan,Karl Quint,Francesco Nicolini,Niccola Funel,Adam E. Frampton,Mina Maftouh,Serena Pelliccioni,Gerrit J. Schuurhuis,Godefridus J. Peters,Elisa Giovannetti
Inhibition of c-Met with the Specific Small Molecule Tyrosine Kinase Inhibitor SU11274 Decreases Growth and Metastasis Formation of Experimental Human Melanoma
Journal: Current Cancer Drug Targets
Volume: 10 Issue: 3 Year: 2010 Page: 332-342
Author(s): I. Kenessey, M. Keszthelyi, Z. Kramer, J. Berta, A. Adam, J. Dobos, M. Mildner, B. Flachner, S. Cseh, G. Barna, B. Szokol, L. Orfi, G. Keri, B. Dome, W. Klepetko, J. Timar, J. Tovari
Synergistic Activity of the c-Met and Tubulin Inhibitor Tivantinib (ARQ197) with Pemetrexed in Mesothelioma Cells
Journal: Current Drug Targets
Volume: 15 Issue: 14 Year: 2014 Page: 1331-1340
Author(s): Leticia G. Leon,Maria Gemelli,Rocco Sciarrillo,Amir Avan,Niccola Funel,Elisa Giovannetti